#$%^&*AU2019204496A120190718.pdf#####ABSTRACT An oral formulation of bromelain effective to treat and prevent diarrhea caused by pathogenic microbes. This formulation does not kill pathogenic microbes, and thus does not facilitate the proliferation of anti-microbial resistant organisms. The invention entails formulating an aqueous 5 oral suspension of bromelain, Blanose sodium carboxymethyl cellulose, citric acid anhydrous, Epikuron 135F lecithin oil and ehtylenedinitrilotetraacetic acid, disodium salt dihydrate ("EDTA"). Figure 3 26My Formulation 2 0Control 0 U Z 5 S 10 z 0 2 4 6 8 1 12 14 16 18 20 22 24 26 28 30 32 34 36 Day post weaning Figure 3-Onegroup of piglets wasadministeredasingle oral dose (4mL of My formulation at weaning(day0),or wereuntreated (Control). Myformulationsignificantly reducedthe incidence of scour (diarrhoea)(P<；0.05). 3/4
